Nanoparticulated IFNγ could concentrate on the ablation site and play a long-term regulatory role in the tumor immune microenvironment after iRFA treatment through slow release, while avoiding toxic and side effects of IFNγ on surrounding normal tissues and the whole body. Here, IFNG is linked to neoplasm.